The Gfi-1B proto-oncoprotein represses p21(WAF1) and inhibits myeloid cell differentiation

Molecular and Cellular Biology

Volumn 18, Issue 5, 1998, Pages 2462-2473

  Tong, Betty ^a,c   Grimes, H Leighton ^a,d   Yang, Tong Yuan ^a   Bear, Susan E ^a   Qin, Zhihai ^a,e   Du, Keyong ^b   El Deiry, Wafik S ^b   Tsichlis, Philip N ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 6; ONCOPROTEIN; PROTEIN P21;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE REPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE; RETROVIRUS; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION;

EID: 0031895515     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.18.5.2462     Document Type: Article

References (69)

1. Anderson, S., D. H. Davis, H. Dahlbäck, H. Jörnvall, and D. W. Russell. 1989. Cloning, structure and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile biosynthetic enzyme. J. Biol. Chem. 264: 8222-8229.
2. Arnaout, M. A. 1990. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75:1037-1050.
3. Bell, D. W., T. Taguchi, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, C. B. Gilks, P. Zweidler-McKay, H. L. Grimes, P. N. Tsichlis, and J. R. Testa. 1995. Chromosomal localization of a gene, GFI1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents. Cytogenet. Cell Genet. 70:263-267.
4. Bies, J., B. Hoffman, A. Amanullah, T. Giese, and L. Wolff. 1996. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene 12:355-363.
5. Biggs, J. R., J. E. Kudlow, and A. S. Kraft. 1996. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271:901-906.
6. Bignon, C., D. Daniel, and J. Dijiane. 1993. β-Galactosidase and chloramphenicol acetyltransferase assays in 96-well plates. BioTechniques 15:243-245.
7. Bosari, S., and G. Viale. 1995. The clinical significance of p53 aberrations in human tumors. Virchows Arch. 427:229-241.
8. Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X. Y. Fu. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272:719-722.
9. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
10. Collins, S. J., S. Tsai, and I. Bernstein. 1996. Retinoic acid receptors in hematopoiesis. Curr. Top. Microbiol. Immunol. 211:7-15.
11. Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, R. C. Bast, Jr., J. D. Iglehart, and J. R. Marks. 1994. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1301-1307.
12. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
13. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55:2910-2919.
14. Elledge, S. J., J. Winston, and J. W. Harper. 1996. A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol. 6:388-392.
15. Gearing, D. P., N. M. Gough, J. A. King, D. J. Hilton, N. A. Nicola, R. J. Simpson, E. C. Nice, A. Kelso, and D. Metcalf. 1987. Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBO J. 6:3995-4002.
16. Gilks, C. B., S. E. Bear, H. L. Grimes, and P. N. Tsichlis. 1993. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol. Cell. Biol. 13:1759-1768.
17. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
18. Graña, X., and E. P. Reddy. 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219.
19. 1 arrest induced by interleukin-2 withdrawal. Mol. Cell. Biol. 16:6263-6272.
20. Grimes, H. L., C. B. Gilks, T. O. Chan, S. Porter, and P. N. Tsichlis. 1996. The Gfi-1 proto-oncoprotein represses Bax expression and inhibits T-cell death. Proc. Natl. Acad. Sci. USA 93:14569-14573.
21. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
22. Harper, J. W., and S. J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56-64.
23. Harvey, D. M., and A. J. Levine. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5:2375-2385.
24. Hawley, R. G., F. H. L. Lieu, A. Z. C. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:1-11.
25. Hoffman-Liebermann, B., and D. A. Liebermann. 1991. Interleukin-6-and leukemia inhibitory factor-induced terminal differentiation of mycloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol. Cell. Biol. 11:2375-2381.
26. Hoffman-Liebermann, B., and D. A. Liebermann. 1991. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells. Oncogene 6:903-909.
27. Jiang, H., J. Lin, Z. Z. Su, F. R. Collart, E. Huberman, and P. B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-3406.
28. Johnson, M., D. Dimitrov, P. J. Vojta, J. C. Barrett, A. Noda, O. M. Pereira-Smith, and J. R. Smith. 1994. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinog. 11:59-64.
29. Kelley, K. W., S. Arkins, C. Minshall, Q. Liu, and R. Dantzer. 1996. Growth hormone, growth factors and hematopoiesis. Horm. Res. 45:38-45.
30. Kramer, A., and W. Keller. 1990. Preparation and fractionation of mammalian extracts active in pre-mRNA splicing. Methods Enzymol. 181:3-19.
31. Krystosek, A., and L. Sachs. 1976. Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell 9:675-684.
32. Lan, M. S., E. K. Russell, J. Lu, B. E. Johnson, and A. L. Notkins. 1993. IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Cancer Res. 53:4169-4171.
33. Lew, D. J., and S. Kornbluth. 1996. Regulatory roles of cyclin-dependent kinase phosphorylation in cell cycle control. Curr. Opin. Cell Biol. 8:795-804.
34. Li, H., P. S. Zeitler, M. T. Valerius, K. Small, and S. S. Potter. 1996. Gsh-1, an orphan Hox gene, is required for normal pituitary development. EMBO J. 15:714-724.
35. Liebermann, D. A., and B. Hoffman. 1994. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Stem Cells 12:352-369.
36. Liu, M., M. H. Lee, M. Cohen, M. Bommakanti, and L. P. Freedman. 1996. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10: 142-153.
37. Liu, M., A. Iavarone, and L. P. Freedman. 1996. Transcriptional activation of the human p21 (WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271: 31723-31728.
38. Meier, R. W., T. Chen, S. Mathews, G. Niklaus, and A. Tobler. 1992. The differentiation pathway of HL60 cells is a model system for studying the specific regulation of some myeloid genes. Cell Growth Differ. 3:663-669.
39. Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:3391-3395.
40. Mikkers, H., and A. Berns. Personal communication.
41. Missero, C., F. Di Cunto, H. Kiyokawa, A. Koff, and G. P. Dotto. 1996. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10:3065-3075.
42. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
43. Orkin, S. H. 1996. Development of hematopoietic system. Curr. Opin. Genet. Dev. 6:597-602.
44. Prowse, D. M., L. Bolgan, A. Molnar, and G. P. Dotto. 1997. Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation. J. Biol. Chem. 272:1308-1314.
45. Puri, P. L., M. L. Avantaggiati, C. Balsano, N. Sang, A. Graessmann, A. Giordano, and M. Levrero. 1997. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16:369-383.
46. Ryan, K., I. Hayes, R. J. B. Nibbs, J. W. Baird, B. Tong, P. N. Tsichlis, J. D. Ansell, N. Hole, and G. J. Graham. Submitted for publication.
47. Sachs, L. 1990. The control of growth and differentiation in normal and leukemic blood cells. Cancer 65:2196-2206.
48. Sachs, L. 1996. The control of hematopoiesis and leukemia: from basic biology to the clinic. Proc. Natl. Acad. Sci. USA 93:4742-4749.
49. Scheijen, B., J. Jonkers, D. Acton, and A. Berns. 1997. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J. Virol. 71:9-16.
50. Schmidt, T., M. Zornig, R. Beneke, and T. Moroy. 1996. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene. Nucleic Acids Res. 24:2528-2534.
51. Selvakumaran, M., D. A. Liebermann, and B. Hoffman-Liebermann. 1992. Deregulated c-myb disrupts interleukin-6-or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis. Mol. Cell. Biol. 12:2493-2500.
52. Shabo, Y., J. Lotem, M. Rubinstein, M. Revel, S. C. Clark, S. F. Wolf, R. Kamen, and L. Sachs. 1988. The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood 72:2070-2073.
53. Sherley, J. L., and T. J. Kelly. 1988. Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem. 263:8350-8358.
54. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
55. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
56. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024.
57. CIP1-mediated inhibition ot cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11:1674-1689.
58. WAF1/CIP1. Nature 389:187-190.
59. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. el-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396.
60. Timchenko, N. A., M. Wilde, M. Nakanishi, J. R. Smith, and G. J. Darlington. 1996. CCAAT/enhancer-binding protein α (C/EBP α) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10: 804-815.
61. WAF1 expression and inhibits myeloid cell differentiation. Ph.D. thesis. University of Pennsylvania, Philadelphia.
62. Tong, B., N. Copeland, and N. Jenkins. Unpublished data.
63. Vasavada, H. A., S. Ganguly, F. J. Germino, Z. X. Wang, and S. M. Weissman. 1991. A contingent replication assay tor the detection of protein-protein interactions in animal cells. Proc. Natl. Acad. Sci. USA 88:10686-10690.
64. Weeks, D. L., and N. C. Jones. 1983. E1A control of gene expression is mediated by sequences 5′ to the transcriptional starts of the early viral genes. Mol. Cell. Biol. 3:1222-1234.
65. Yonisn-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352:345-347.
66. Zanjani, E. D., G. Almeida-Porada, and A. W. Flake. 1996. The human/sheep xenograft model: a large animal model of human hematopoiesis. Int. J. Hematol. 63:179-192.
67. Zeng, Y. X., K. Somasundaram, and W. S. El-Deiry. 1997. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat. Genet. 15: 78-82.
68. Zhang, D. E., S. Hohaus, M. T. Voso, H. M. Chen, L. T. Smith, C. J. Hetherington, and D. G. Tenen. 1996. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr. Top. Microbiol. Immunol. 211:137-147.
69. Zweidler-McKay, P. A., H. L. Grimes, M. M. Flubacher, and P. N. Tsichlis. 1996. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol. Cell. Biol. 16:4024-4034.